Hypoglycaemic effect of resveratrol in streptozotocin-induced diabetic rats is impaired when supplemented in association with leucine

References

• Alberti G, Macarulla MT, Portillo MP, Rodríguez VM. 2014. Resveratrol does not increase body fat loss induced by energy restriction. J Physiol Biochem. 70:639–646.
   PubMed Web of Science ®Google Scholar
• Alberti G, Rodríguez VM, Miranda J, Macarulla MT, Arias N, Andrés-Lacueva C, Portillo MP. 2011. Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr Metab (Lond). 8:2–7.
   PubMed Web of Science ®Google Scholar
• Alonso-Vale, MIC, Andreotti, S, Peres SB, Anhê GF, das Neves Borges-Silva C, Neto JC, Lima FB. 2005. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab. 288:805–812.
   Google Scholar
• Azachi M, Yatuv R, Katz A, Hagay Y, Danon A. 2014. A novel red grape cells complex: health effects and bioavailability of natural resveratrol. Int J Food Sci Nutr. 65:848–855.
   PubMed Web of Science ®Google Scholar
• Banerjee J, Bruckbauer A, Zemel MB. 2016. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans. Metab Clin Exp. 65:1679–1691.
   PubMed Web of Science ®Google Scholar
• Bernard JR, Liao YH, Ding Z, Hara D, Kleinert M, Nelson JL, Ivy JL. 2013. An amino acid mixture improves glucose tolerance and lowers insulin resistance in the obese Zucker rat. Amino Acids. 45:191–203.
   PubMed Web of Science ®Google Scholar
• Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M. 1989. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 68:374–378.
   PubMed Web of Science ®Google Scholar
• Bruckbauer A, Zemel MB. 2013. Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity. Diabetes Metab Syndr Obes. 6:93–102.
   PubMedGoogle Scholar
• Bruckbauer A, Zemel MB. 2014. Synergistic effects of polyphenols and methylxanthines with leucine on AMPK/Sirtuin-mediated metabolism in muscle cells and adipocytes. PloS One. 9:e89166.
   PubMed Web of Science ®Google Scholar
• Bruckbauer A, Zemel MB, Thorpe T, Akula MR, Stuckey AC, Osborne D, Martin EB, Kennel S, Wall JS. 2012. Synergistic effects of leucine and resveratrol insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 9:77–12.
   PubMed Web of Science ®Google Scholar
• Chi TC, Chen WP, Chi TL, Kuo TF, Lee SS, Cheng JT, Su MJ. 2007. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci. 80:1713–1720.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156–159.
   PubMed Web of Science ®Google Scholar
• Fu L, Bruckbauer A, Li F, Cao Q, Cui X, Wu R, Shi H, Zemel MB, Xue B. 2015. Leucine amplifies the effects of metformin on insulin sensitivity and glycemic control in diet-induced obese mice. Metabolism. 64:845–856.
   PubMed Web of Science ®Google Scholar
• Gencoglu H, Tuzcu M, Hayirli A, Sahin K. 2015. Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. Int J Food Sci Nutr. 66:314–320.
   PubMed Web of Science ®Google Scholar
• Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. 1967. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 126:201–205.
   PubMed Web of Science ®Google Scholar
• Junod A, Lambert AE, Stauffacher W, Renold AE. 1969. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J Clin Invest. 48:2129–2139.
   PubMed Web of Science ®Google Scholar
• Lasa A, Churruca I, Eseberri I, Andrés‐Lacueva C, Portillo MP. 2012. Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol Nutr Food Res. 56:1559–1568.
   PubMed Web of Science ®Google Scholar
• Oliveira AC, Andreotti S, Farias TDS, Torres-Leal FL, de Proença AR, Campaña AB, de Souza AH, et al. 2012. Metabolic disorders and adipose tissue insulin responsiveness in neonatally STZ-induced diabetic rats are improved by long-term melatonin treatment. Endocrinology. 153:2178–2188.
   PubMed Web of Science ®Google Scholar
• Palsamy P, Subramanian S. 2008. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother. 62:598–605.
   PubMed Web of Science ®Google Scholar
• Palsamy P, Subramanian S. 2010. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol. 224:423–432.
   PubMed Web of Science ®Google Scholar
• Portha B, Blondel O, Serradas P, McEvoy R, Giroix MH, Kergoat M, Bailbe D. 1989. The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabete Metab. 15:61–75.
   PubMed Web of Science ®Google Scholar
• Rezaei Farimani A, Saidijam M, Goodarzi MT, Yadegar Azari R, Asadi S, Zarei S, Shabab N. 2015. Effect of resveratrol supplementation on the SNARE proteins expression in adipose tissue of stroptozotocin-nicotinamide induced type 2 diabetic rats. Iran J Med Sci. 40:248.
   PubMed Web of Science ®Google Scholar
• Schwartz GJ. 2013. Central leucine sensing in the control of energy homeostasis. Endocrinol Metab Clin North Am. 42:81.
   PubMed Web of Science ®Google Scholar
• Stipanuk MH. 2007. Leucine and protein synthesis: mTOR and beyond. Nutr Rev. 65:122–129.
   PubMed Web of Science ®Google Scholar
• Takada J, Fonseca-Alaniz MH, de Campos TBF, Andreotti S, Campana AB, Okamoto M, Borges-Silva C, Machado UF, Lima FB. 2008. Metabolic recovery of adipose tissue is associated with improvement in insulin resistance in a model of experimental diabetes. J Endocrinol. 198:51–60.
   PubMed Web of Science ®Google Scholar
• Takada J, Machado MA, Peres SB, Brito LC, Borges-Silva CN, Costa CE, Fonseca-Alaniz MH, Andreotti S, Lima FB. 2007. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass. Metabolism. 56:977–984.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun X, Li X, Dong X, Li P, Zhao L. 2015. Resveratrol attenuates intermittent hypoxia‑induced insulin resistance in rats: involvement of Sirtuin 1 and the phosphatidylinositol‑4, 5‑bisphosphate 3‑kinase/AKT pathway. Mol Med Rep. 11:151–158.
   PubMed Web of Science ®Google Scholar
• Zampieri TT, Torres-Leal F, Campaña A, Lima F, Donato J. 2014. L-Leucine supplementation worsens the adiposity of already obese rats by promoting a hypothalamic pattern of gene expression that favors fat accumulation. Nutrients. 6:1364–1373.
   PubMed Web of Science ®Google Scholar
• Zanchi NE, Guimarães-Ferreira L, Siqueira-Filho MA, Camporez JPG, Nicastro H, Chaves DFS, Campos-Ferraz P, Lancha AH Jr, de Oliveira Carvalho CR. 2012. The possible role of leucine in modulating glucose homeostasis under distinct catabolic conditions. Med Hypotheses. 79:883–888.
   PubMed Web of Science ®Google Scholar
• Zeanandin G, Balage M, Schneider SM, Dupont J, Hébuterne X, Mothe-Satney I, Dardevet D. 2012. Differential effect of long-term leucine supplementation on skeletal muscle and adipose tissue in old rats: an insulin signaling pathway approach. Age. 34:371–387.
   PubMedGoogle Scholar
• Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. 2007. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes. 56:1647–1654.
   PubMed Web of Science ®Google Scholar